No. | Aspect | Statement | Consensus % | Voters |
1 | DM | “The BEAT-PCD network suggests use of Gram-staining and microscopy as part of clinical microbiological diagnostics at PCD centres where this service is available” | 78.6 | 14/18 |
2 | DM | “The BEAT-PCD network suggests investigating for viral respiratory infections in case of a clinical exacerbation” | 72.8 | 18/18 |
3 | DM | “The BEAT-PCD network suggests routine bacterial typing at first positive culture of Achromobacter xylosoxidans” | 71.4 | 14/18 |
4 | DM | “The BEAT-PCD network suggests routine bacterial typing at first positive culture of Pseudomonas aeruginosa” | 57.2 | 14/18 |
5 | IT | “The BEAT-PCD network suggests that cultured Achromobacter xylosoxidans is treated regardless of symptoms and microscopy” | 66.7 | 18/18 |
6 | S | “The BEAT-PCD network suggests that patients with Achromobacter xylosoxidans should be segregated in outpatient and in-patient settings” | 77.8 | 18/18 |
7 | S | “The BEAT-PCD network suggests to always have a 30-minute wait between all PCD patients regardless of infection status” | 72.8 | 18/18 |
Seven proposed consensus statements did not reach consensus during the Delphi process. Each proposed statement was presented for the expert panel using a Likert scale offering five possible response options: “Strongly agree”, “Agree”, “Neutral”, “Disagree”, “Strongly disagree”. “No consensus” was defined as <80% agreement (“Strongly agree” or “Agree”) within the PCD expert panel. DM: diagnostic microbiology aspects; IT: infection treatment aspects; S: segregational aspects. Voters: 18 PCD experts responded to the E-surveys.